# A Study of Abemaciclib in Healthy Participants

> **NCT02677844** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 35 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Abemaciclib
- **DRUG:** Placebo
- **DRUG:** Loperamide

## Key facts

- **NCT ID:** NCT02677844
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677844, "A Study of Abemaciclib in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02677844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*